Analysis of the Epigenetic Mechanism and Treatment of Huntington’s Disease

Huntington’s disease (HD) is an irreversible neurodegenerative disorder that is inherited in an autosomal dominant manner. In HD, many regions of the human brain are affected, including the striatum, thalamus, and cortex. The mechanism is by the expansion of CAG repeats, which encode glutamine (Q) in the Huntingtin gene on chromosome 4p16.3. Patients with more CAG repeats tend to have a younger age of onset and a higher risk. Mutant HTT protein, translated from mtHtt, would congregate or interact with other proteins, causing damage to the human body. Patients with HD show symptoms like chorea, which is an involuntary motor disability, cognitive deterioration, and psychiatric disturbances. Except for the genetic pathology of HD, the epigenetic mechanism of this disease has made a lot of progress in recent years. This paper primarily focuses on the alternation of deoxyribonucleic acid (DNA) methylation, histone modification, and non-coding ribonucleic acids (ncRNAs) in HD as well as the advancements of epigenetic therapy and healthcare in HD.

• Publication year

  2022

• Venue

  Proceedings of Anticancer Research

• Publication date

  2022-11-17

• Fields of study

  Not labeled

• Identifiers
  DOI 10.26689/par.v6i6.4512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Upcoming Meetings Related to Huntington’s Disease

  2022cited by this paper
• DNA Methylation in Huntington’s Disease

  2021cited by this paper
• Contribution of Neuroepigenetics to Huntington’s Disease

  2017cited by this paper
• Epigenetics of Huntington's Disease.

  2017cited by this paper
• DNA methylation in Huntington's disease: Implications for transgenerational effects.

  2016cited by this paper
• Understanding histone deacetylation in Huntington’s disease

  2016cited by this paper
• What Do You Mean, “Epigenetic”?

  2015cited by this paper
• The epigenetics of aging and neurodegeneration.

  2015influential reference
• Mammalian epigenetic mechanisms

  2014cited by this paper
• Genome-Wide Increase in Histone H2A Ubiquitylation in a Mouse Model of Huntington's Disease

  2013cited by this paper
• Extensive changes in DNA methylation are associated with expression of mutant huntingtin

  2013cited by this paper
• A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.

  2013cited by this paper
• Multiple Aspects of Gene Dysregulation in Huntington’s Disease

  2013cited by this paper
• Epigenetic Mechanisms of Neurodegeneration in Huntington’s Disease

  2013cited by this paper
• Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease

  2013cited by this paper
• Epigenetics and ncRNAs in Brain Function and Disease: Mechanisms and Prospects for Therapy

  2013cited by this paper
• Functions of DNA methylation and hydroxymethylation in mammalian development.

  2013cited by this paper
• Targeting Huntington’s disease through histone deacetylases

  2011cited by this paper
• SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease

  2011influential reference
• Huntington's disease: a clinical review

  2010cited by this paper
• Epigenetic modifications and human disease

  2010cited by this paper
• Histone modification patterns and epigenetic codes.

  2009cited by this paper
• A microRNA-based gene dysregulation pathway in Huntington's disease.

  2008cited by this paper
• The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice

  2008cited by this paper
• Histone Deacetylase Inhibitors: Overview and Perspectives

  2007influential reference
• Mechanisms of Disease: histone modifications in Huntington's disease

  2006influential reference
• The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.

  2005cited by this paper
• p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

  2005cited by this paper
• DNA methylation and the regulation of gene transcription

  2002cited by this paper
• What do you mean

  1998cited by this paper
• Roles of histone acetyltransferases and deacetylases in gene regulation

  1998cited by this paper

• No citing papers are available for this paper.